Corneal ectasia is a serious complication of laser in situ keratomileusis (LASIK). We report the case of a 29-year-old man who underwent LASIK in both eyes and in whom corneal ectasia developed in the left eye 3 years after surgery. He was treated sequentially with intraocular pressure-lowering medication, intrastromal corneal ring segment (ICRS) implants, and collagen cross-linking. Vision improved and the ectasia stabilized following treatment. Combined ICRS implantation and collagen cross-linking should be considered early in the management of post-LASIK ectasia.
Introduction
Corneal ectasia is a serious vision-threatening complication of laser in situ keratomileusis (LASIK). 1 It is associated with progressive corneal steepening, an increase in myopia and astigmatism, and decrease in uncorrected visual acuity. These cases can be managed with lamellar or penetrating keratoplasty; however, minimally invasive techniques are also possible. These options include medication to reduce intraocular pressure (IOP), 2 rigid gas-permeable contact lenses, intrastromal corneal ring segments (ICRSs), [3] [4] [5] and corneal cross-linking with ultraviolet radiation and riboflavin treatment. 6 
Case Report
A 32-year-old man presented at Yonge Eglinton Laser Eye Centre with a complaint of deteriorating and variable visual acuity of several weeks' duration. His medical history was remarkable for LASIK surgery 3 years earlier. On preoperative examination, his best-corrected visual acuity had been 20/20, with a manifest refraction of −6.00 −0.50 × 10 in the right eye and −7.00 −0.50 × 180 in the left eye. Slit-lamp examination and fundus examination were normal. The preoperative topography had revealed no significant irregularities. Keratometry Attempts to lower the patient's IOP with brimonidine on the left showed no change in corneal topography. ICRSs (Intacs; Addition Technology, Sunnyvale, CA) were implanted in the left eye using the femtosecond laser for tunnel creation. Two standard segment implants of 400 μm (7.0 mm optical zone) were placed at axis 60, with a tunnel depth of 400 μm. The implants resulted in some improvement (see Table 1 for visual and keratometric results), but the patient still experienced variable visual acuity. Post-ICRS topography is shown in Figure 2 . As a result of these concerns, 10 months after ICRS insertion, the ectatic left cornea was treated with combined ultraviolet radiation and riboflavin treatment to achieve collagen cross-linking. At 7 months after treatment, his uncorrected visual acuity improved from 20/60 to 20/25; his best-corrected visual acuity, from 20/30 to 20/20. His refraction changed from −6.50 + 2.50 × 180 to +0.25 + 1.00 × 30. Changes in the patient's corneal topography are given in Table 1 and Figure 3 . The right eye remained stable throughout treatment. Figure 4 shows the difference maps to reflect the treatment's effect after ICRS and cross-linking procedures.
Discussion
Iatrogenic corneal ectasia after LASIK is one of the most feared complications of refractive surgery. 7 This progressive corneal distortion can result in progressive myopia, irregular astigmatism, and visual impairment. 8 Rigid contact lenses are frequently required to achieve good functional vision, but ectatic progression can lead to intolerance of contact lenses, and ultimately the Table 1 . Visual, refractive, and keratometric parameters in the left eye on presentation, after Icrs implantation, and after collagen cross-linking patients may require lamellar or penetrating keratoplasty. The use of Intacs for post-LASIK ectasia has been previously reported with positive results. 4, 5, 9, 10 Treatment of post-LASIK ectasia with cross-linking procedures has also shown promise. 6, 11 Combined Intacs and collagen cross-linking treatment has been reported previously for one patient, who achieved a stable best-corrected visual acuity of 20/25. 12 Combined ICRS implantation and collagen cross-linking produced a dramatic, stable visual outcome in our patient. While IOP-lowering medication did not seem to improve our patient's condition, we feel that, as a lowrisk intervention with previously reported utility, 2 it may be worthwhile to attempt. The efficacy of this approach is clearly limited, however, and now we would generally consider more aggressive strategies at the outset. When our patient presented, cross-linking therapy was not yet available, and IOP control as a temporizing measure seemed appropriate.
ICRS implantation in the corneal periphery flattens the central corneal apex, 3 while cross-linking induces additional covalent bonds between collagen molecules to increase corneal strength. 11 A patient receiving both treatments consecutively may receive the beneficial effects of improved corneal topography and stabilization of corneal ectasia. We believe that a stepwise progression from IOP-lowering medication to ICRS implantation to collagen cross-linking may be an appropriate treatment strategy for cases of post-LASIK corneal ectasia. We did not combine our treatment measures with photorefractive keratectomy (PRK), as described by Kanellopoulos in the Athens Protocol, 13 because we have had little experience with this modality and also because the long-term results of further corneal thinning and destabilization remain uncertain.
The combination of these two minimally invasive therapies, Intacs and cross-linking, for the treatment of post-LASIK ectasia appears to be a promising alternative to lamellar or penetrating lamellar keratoplasty. Longer follow-up and larger studies are needed to evaluate the refractive and topographic stability of these alternative and desirable treatment options.
